Jupiter Neurosciences, Inc.Jupiter Neurosciences, Inc.Jupiter Neurosciences, Inc.

Jupiter Neurosciences, Inc.

No trades
See on Supercharts
Market capitalization
‪357.04 M‬USD
‪−4.78 M‬USD
0.00USD
Beta (1Y)

About Jupiter Neurosciences, Inc.


CEO
Christer Rosén
Headquarters
Jupiter
FIGI
BBG0130XFNK0
Jupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company engaged in treating neuroinflammation with a current focus on CNS disorders and rare diseases. The firm offers JOTROL, an enhanced orally administered resveratrol formulation, designed to deliver therapeutically relevant, safe levels of resveratrol. The company was founded by Christer Rosén, Alexander Rosén, Claes Wahlestedt, Marshall Hayward, and Shaun P. Brothers in January 2016 and is headquartered in Jupiter, FL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of JUNS is 9.73 USD — it has decreased by −10.41% in the past 24 hours. Watch Jupiter Neurosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Jupiter Neurosciences, Inc. stocks are traded under the ticker JUNS.
JUNS stock has fallen by −43.56% compared to the previous week, the month change is a 143.25% rise, over the last year Jupiter Neurosciences, Inc. has showed a 143.25% increase.
JUNS reached its all-time high on Dec 12, 2024 with the price of 19.00 USD, and its all-time low was 3.86 USD and was reached on Dec 3, 2024. View more price dynamics on JUNS chart.
See other stocks reaching their highest and lowest prices.
Today Jupiter Neurosciences, Inc. has the market capitalization of ‪357.04 M‬, it has increased by 3.39% over the last week.
Yes, you can track Jupiter Neurosciences, Inc. financials in yearly and quarterly reports right on TradingView.
JUNS net income for the last quarter is ‪313.12 K‬ USD, while the quarter before that showed ‪−634.10 K‬ USD of net income which accounts for 149.38% change. Track more Jupiter Neurosciences, Inc. financial stats to get the full picture.
No, JUNS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, JUNS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Jupiter Neurosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.